Aimee
Aimee Chen, Nantong CN
Patent application number | Description | Published |
---|---|---|
20150359357 | COMPRESSIBLE MATTRESS - In an implementation a compressible mattress is provided that may be compressed at a manufacturing location and inserted into packaging; the packaging, maintaining the compressed state of the compressed mattress. The compressed mattress may be shipped in the compressed state within the packaging to a distributor or retail store for display and sale. After sale and transport to a customer location in the compressed state, the packaging may be removed and the mattress decompresses and expands until it reaches an expanded form. | 12-17-2015 |
Aimee Cossins, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20150247139 | RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS - The invention provides a nucleic acid sequence comprising a sequence of contiguous nucleotides, wherein said sequence of contiguous nucleotides has at least 90% sequence identity to the nucleic acid sequence of SEQ ID NO: 1, and wherein said sequence of contiguous nucleotides encodes a single-chain BoNT/E1 protein. The present invention also provides methods for producing soluble single-chain BoNT/E1 protein in an | 09-03-2015 |
Aimee Cossins, Oxfordshire GB
Patent application number | Description | Published |
---|---|---|
20110177056 | NON-CYTOTOXIC FUSION PROTEINS COMPRISING EGF MUTEINS - The present invention relates to fusion proteins comprising a non-cytotoxic protease and a EGF mutein ligand. The EGF mutein provides improved EGF receptor activation for the claimed fusion proteins. Also provided is the use of said polypeptides as therapeutics for suppressing mucus hypersecretion, inflammation, endocrine neoplasia and/or neuroendocrine disorders, neuroendocrine tumours, for suppressing cancers such as colorectal cancer, prostate cancer, breast cancer, and lung cancer. | 07-21-2011 |
Aimee Dessinges, Ruiel-Malmaison FR
Patent application number | Description | Published |
---|---|---|
20090075982 | Piperazine compounds - A compound selected from those of formula (I): | 03-19-2009 |
20090076030 | Piperazine compounds - A compound selected from those of formula (I): | 03-19-2009 |
Aimee El Hed, Morrisville, NC US
Patent application number | Description | Published |
---|---|---|
20120251523 | Methods of Modulating TGFbeta Signaling - The present invention provides methods of identifying the presence of or quantifying the amount of one or more of T helper (Th) cells and iTreg cells present in a sample by identifying the presence of an ADAM or the amount of an ADAM, such as ADAM12, present in a sample. The present invention also provides methods for increasing or decreasing signaling of a TGF such as TGFβ by increasing or decreasing the biological activity or expression of an ADAM. Further, the present invention provides methods for inhibiting or stimulating, downregulating or upregulating, an immune response, and for treating diseases associated with an immune response such as cancer, viral, bacterial and fungal infections, autoimmune diseases and graft versus host diseases. Still further, the invention provides screening methods effective for identifying therapeutic agents, pharmaceutical compositions containing therapeutic agents, and vaccines. | 10-04-2012 |
Aimee Freeding, London GB
Patent application number | Description | Published |
---|---|---|
20130097565 | LEARNING VALIDATION USING GESTURE RECOGNITION - Embodiments are disclosed that relate to assessing a user's ability to recognize a target item by reacting to the target item and performing a target gesture. For example, one disclosed embodiment provides a method of assessing a user's ability to recognize a target item from a collection of learning items that includes the target item. The method includes providing to a display device the learning items in a sequence and receiving input from a sensor to recognize a user gesture made by the user. If the user gesture is received within a target timeframe corresponding to the target item, then the method includes determining whether the user gesture matches a target gesture. If the user gesture matches the target gesture, then the method includes providing to the display device a reward image for the user. | 04-18-2013 |
20150141140 | User-Defined Channel - Example apparatus and methods facilitate providing a user-defined channel that presents content from, for example, a virtual video playlist. The playlist may include raw or edited dips of user-generated video content (e.g., video game highlights, smart phone recordings). The clips may be edited with sound, text, graphics, special effects or in other ways and then organized into the playlist. The playlist may be organized to facilitate presenting a collection of clips as a continuous show. For example, a user may produce a playlist of goals scored in their favorite video game. The highlights may be of goals scored by the user, in which case the video may come from the user's device, or of goals scored by other players, in which case the video may come from another users device or playlist. Playback of the playlist may be manipulated with respect to order, frequency, or other parameters. | 05-21-2015 |
Aimee Mcdaniel-Laut, South Glastonbury, CT US
Patent application number | Description | Published |
---|---|---|
20140094699 | PROCESS FOR PRODUCING A RADIOLOGY REPORT - A process for manufacturing a radiology report wherein a first technologist prepares a worksheet that records objective data from the image display of the condition of a patient's body that was subjected to a controlled source of imaging energy. A second different technologist prepares a preliminary report in narrative form from the work sheet prepared by the first technologist and image display. A radiologist uses the preliminary report and the image to prepare a final report. | 04-03-2014 |
Aimee Parow, Phoenix, AZ US
Patent application number | Description | Published |
---|---|---|
20120022315 | Magnetic Field Treatment Techniques - The invention involves enhancing brain function by stimulating the brain using magnetic fields. Applications of the new methods include improving the condition of individuals with cognitive disorders, such as depression, and studying the effects of neural stimulation using induced electric fields. These techniques can avoid deleterious effects of psychotropic pharmaceutical treatments, and provide a relatively safe, comfortable, inexpensive means of direct cranial stimulation. | 01-26-2012 |
20130066138 | Magnetic Field Treatment Techniques - The invention involves enhancing brain function by stimulating the brain using magnetic fields. Applications of the new methods include improving the condition of individuals with cognitive disorders, such as depression, and studying the effects of neural stimulation using induced electric fields. These techniques can avoid deleterious effects of psychotropic pharmaceutical treatments, and provide a relatively safe, comfortable, inexpensive means of direct cranial stimulation. | 03-14-2013 |
Aimee Parow, New York, NY US
Patent application number | Description | Published |
---|---|---|
20160001074 | Magnetic Field Treatment Techniques - The invention involves enhancing brain function by stimulating the brain using magnetic fields. Applications of the new methods include improving the condition of individuals with cognitive disorders, such as depression, and studying the effects of neural stimulation using induced electric fields. These techniques can avoid deleterious effects of psychotropic pharmaceutical treatments, and provide a relatively safe, comfortable, inexpensive means of direct cranial stimulation. | 01-07-2016 |
Aimee Powelka, Framingham, MA US
Patent application number | Description | Published |
---|---|---|
20090221676 | GLUCOSE-TRANSPORT RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF - Methods and compositions for modulating glucose transport are provided herein. | 09-03-2009 |
20100098638 | RIP140 Regulation of Diabetes - Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat. | 04-22-2010 |
20120208862 | RIP140 REGULATION OF GLUCOSE TRANSPORT - Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat. | 08-16-2012 |
Aimee Reynolds, Bondi Junction AU
Patent application number | Description | Published |
---|---|---|
20140305899 | Bottle closure and method of using the same - A bottle closure ( | 10-16-2014 |
Aimee Sealfon, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20120253308 | ARTICLE INCLUDING VISUAL SIGNAL FOR COMMUNICATION OF A FUNCTIONAL BENEFIT - The present invention provides an absorbent article including a longitudinally extending a top surface, a cover layer, a barrier layer, an absorbent core arranged between the cover layer and the barrier layer, a printed portion, a plurality of non-printed portions, wherein the printed portion and the plurality of non-printed portions are arranged to create a perception of a functional benefit by a user looking upon the top surface of the absorbent article. | 10-04-2012 |
Aimee Shen, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20130012687 | INDUCIBLE SELF-CLEAVING PROTEASE TAG AND METHOD OF PURIFYING RECOMBINANT PROTEINS USING THE SAME - A method of purifying a protein is disclosed which entails: a) fusing a site-specific affinity-tagged cysteine protease domain to a target protein to form a tagged fusion protein; b) activating the site-specific cysteine protease domain of the tagged fusion protein by subjecting the site-specific affinity-tagged cysteine protease domain to an inducer, which induces autoprocessing at a cleavage site; thereby releasing untagged target protein; and c) isolating the untagged target protein. | 01-10-2013 |
Aimee St. Georges, Lockeford, CA US
Patent application number | Description | Published |
---|---|---|
20130068812 | Adapter Bracket For Supporting A Saddle Bag On A Motorcycle And Method For Installing Same - An adapter bracket for supporting a saddle bag on a motorcycle. A strut for securing a rear motorcycle fender includes a vertical section, a lower horizontal section, and an upper horizontal section. The vertical section has bolts extending through it for attachment to the fender. The adapter bracket includes a lower attachment portion with bores, an intermediate strut coupling portion, and an upper connection plate with an aperture. One of the fender bolts is removed, and the coupling portion is slid over the lower horizontal section of the strut from the strut's inner side. The aperture in the connection plate is aligned with the hole in the strut corresponding to the removed bolt. The bolt is reinstalled, securing the strut, bracket, and fender together. An inner sidewall of the saddle bag provided with a backing plate, and bolts secure the backing plate, the inner sidewall, and the attachment portion together. | 03-21-2013 |
Aimee Teunckens, Meerhout BE
Patent application number | Description | Published |
---|---|---|
20120215016 | Lipid-Soluble Formulations Containing Mixtures of Antioxidants - A substantially oil- and fat-free single phase, homogenous antioxidant formulation that is readily dispersible in lipid matrices at ambient temperature by gentle stirring. The formulation includes a phenolic antioxidant compound, a liquid carrier, preferably a metal chelator, an emulsifier, and a polarity modifier. In preferred embodiment, a combination of lipid-soluble and water-soluble antioxidant compounds is included to provide an improved antioxidant effect. | 08-23-2012 |
Aimee Tharaldson, Woodbury, MN US
Patent application number | Description | Published |
---|---|---|
20090192807 | Identification of specialty drugs - Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug. | 07-30-2009 |
20110307271 | IDENTIFICATION OF SPECIALTY DRUGS - Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug. | 12-15-2011 |
20120084097 | IDENTIFICATION OF SPECIALTY DRUGS - Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug. | 04-05-2012 |
Aimee Usera, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20150017192 | SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS - The present invention relates to methods and reagents for use in site-selective modification of proteins having lysine residues with functionalized peptides using a chemoenzymatic microbial transglutaminase-mediated reaction. The functionalized proteins may be used for study or therapeutic uses. | 01-15-2015 |
Aimee Willmeno, Eureka, MO US
Patent application number | Description | Published |
---|---|---|
20110153478 | Device and Method for Settlement Optimization - A settlement device for optimizing a transaction includes an input module, a processor, and an output module. The input module receives transaction data of the transaction. The processor determines an optimal location to process the transaction as a function of predetermined rules. The output module transmits the transaction data to the optimal location. | 06-23-2011 |